Skip to main content
Clinical Trials/IRCT20090525001946N11
IRCT20090525001946N11RecruitingPhase 3

Investigating the effects of magnesium sulfate compared to placebo in controlling pain during the first 24 hours after cesarean delivery with spinal anesthesia in pregnant women, a double-blind study

Rasht University of Medical Sciences0 sites118 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 3
Status
Recruiting
Sponsor
Enrollment
118

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
9 years to 45 years (—)
Sex
Female

Inclusion Criteria

  • Cesarean section with spinal anesthesia
  • Placement in class II of anesthesia
  • Being nuli para
  • Acceptable candidate for caesarean section

Exclusion Criteria

  • Magnesium intake 24 hours before surgery
  • History of any surgery
  • Suffering from kidney dysfunction
  • Suffering from heart dysfunction
  • Suffering from Lung dysfunction
  • Suffering from Liver dysfunction
  • Suffering from Myopathy dysfunction
  • Suffering from neuropathy dysfunction
  • Occurrence of severe preeclampsia symptoms
  • Occurrence of eclampsia symptoms
  • Having contraindications for spinal injection such as injection site infection
  • Having contraindications for spinal injection such as coagulation disorders
  • Severe obesity (BMI>30)
  • Treatment with calcium receptor blocking drugs
  • Drug addiction
  • History of long-term use of steroids
  • Allergy to magnesium
  • Multiple pregnancy

Investigators

Sponsor
Rasht University of Medical Sciences

Similar Trials

The effects of magnesium sulfate in... | Clinical Trial